Cited in:


This article has been cited by:

  1. You have free access to this content1
    Sebastián Marciano, Adrián C. Gadano, How to optimize current treatment of genotype 2 hepatitis C virus infection, Liver International, 2014, 34,
  2. 2
    Ching-I Huang, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Ming-Lun Yeh, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Ming-Lung Yu, Wan-Long Chuang, Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection, Journal of Gastroenterology and Hepatology, 2014, 29, 5
  3. You have free access to this content3
    Eleonora Grassi, Alessio Aghemo, How to optimize HCV therapy in genotype 2 patients, Liver International, 2013, 33,
  4. 4
    Erik De Clercq, The race for interferon-free HCV therapies: a snapshot by the spring of 2012, Reviews in Medical Virology, 2012, 22, 6